231 related articles for article (PubMed ID: 23517884)
1. Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
Turkoz I; Fu DJ; Bossie CA; Sheehan JJ; Alphs L
J Affect Disord; 2013 Aug; 150(1):17-22. PubMed ID: 23517884
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
[TBL] [Abstract][Full Text] [Related]
3. Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone.
Fu DJ; Turkoz I; Bossie CA; Patel H; Alphs L
J Affect Disord; 2016 Mar; 193():381-90. PubMed ID: 26802315
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
Macfadden W; Adler CM; Turkoz I; Haskins JT; Turner N; Alphs L
BMC Psychiatry; 2011 Oct; 11():171. PubMed ID: 22034906
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
6. The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort study.
Kulkarni J; Berk M; Fitzgerald PB; de Castella AR; Montgomery W; Kelin K; Brnabic A; Granger RE; Dodd S
J Affect Disord; 2008 Apr; 107(1-3):135-44. PubMed ID: 17889373
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
8. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
[TBL] [Abstract][Full Text] [Related]
9. Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.
Szegedi A; Zhao J; McIntyre RS
J Affect Disord; 2013 Sep; 150(3):745-52. PubMed ID: 23473546
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder.
Youngstrom E; Zhao J; Mankoski R; Forbes RA; Marcus RM; Carson W; McQuade R; Findling RL
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):72-9. PubMed ID: 23480324
[TBL] [Abstract][Full Text] [Related]
11. Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers.
Canuso CM; Schooler N; Carothers J; Turkoz I; Kosik-Gonzalez C; Bossie CA; Walling D; Lindenmayer JP
J Clin Psychopharmacol; 2010 Oct; 30(5):487-95. PubMed ID: 20814330
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder].
Benabarre A; Castro P; Sánchez-Moreno J; Martínez-Arán A; Salamero M; Murru A; Franco C; Vieta E
Actas Esp Psiquiatr; 2009; 37(3):143-7. PubMed ID: 19533426
[TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
[TBL] [Abstract][Full Text] [Related]
14. Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials.
Samara MT; Levine SZ; Leucht S
Pharmacopsychiatry; 2023 Jan; 56(1):18-24. PubMed ID: 35896419
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
Janicak PG; Keck PE; Davis JM; Kasckow JW; Tugrul K; Dowd SM; Strong J; Sharma RP; Strakowski SM
J Clin Psychopharmacol; 2001 Aug; 21(4):360-8. PubMed ID: 11476119
[TBL] [Abstract][Full Text] [Related]
16. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
17. A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents.
Joshi G; Petty C; Wozniak J; Faraone SV; Spencer AE; Woodworth KY; Shelley-Abrahamson R; McKillop H; Furtak SL; Biederman J
Psychopharmacology (Berl); 2013 Jun; 227(3):449-58. PubMed ID: 23397049
[TBL] [Abstract][Full Text] [Related]
18. The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
Berk M; Ng F; Wang WV; Calabrese JR; Mitchell PB; Malhi GS; Tohen M
J Affect Disord; 2008 Feb; 106(1-2):153-8. PubMed ID: 17655936
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
20. Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.
Shansis FM; Reche M; Capp E
J Affect Disord; 2016 Jun; 197():1-7. PubMed ID: 26950019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
